配制以通过无毒溶剂有效和经济地停止失控的聚合
布鲁塞尔，比利时2021年7月19日
苏威开发了吩噻嗪LVT™2330年,东北xt-generation shortstop inhibitor solution available globally and designed to protect against runaway polymerization of acrylic and methacrylic acids, esters and other monomers in bulk storage facilities, transportation tanks and containers.
A runaway polymerization is potentially hazardous due to the reaction becoming uncontrollable and the heat that it produces may lead to a fire or an explosion or rupture of closed storage and transport containers. This uncontrolled polymerization can place people, property and the environment at significant risk.
“Solvay’s new Phenothiazine (PTZ) LVT 2330 comprises a thirty percent active liquid solution of PTZ dissolved into Rhodiasolv Polarclean HSP1 solvent, part of Solvay’s line of powerful, green solvents for industrial applications,” said Dave Vanzin, Technical Service & Development Manager at Solvay. “It was developed as an alternative to the use of N-Methyl-2-pyrrolidone (NMP) widely employed in the USA and the EU as a solvent for shortstop inhibitors but considered a substance of very high concern (SVHC) under REACH regulations.”
Solvay的苯噻嗪LVT™2330比含有溶液的NMP更安全，并且还具有较低的冰点，这对于在较冷气候中的设施和运输非常有利。此外，势噻嗪LVT 2330的高活性PTZ浓度允许在大型和小型装置中部署和存储高效和经济的游击手。
“我们看到这种开创性的游击手抑制剂具有巨大的市场潜力，该抑制剂对北美和欧洲的丙烯酸市场具有无毒和非易失性的溶剂，在这些抗化剂市场上，化学毒性对行业和权威的关注日益增加。”Solvay的全球技术市场经理。“但是，亚洲提供了最大的潜力，在游击手抑制剂不是标准的情况下，直到最近才被更广泛地接受，并用于帮助降低事故的风险。”
Soruce :- Solvay
以前的pressrease
下一个pressRelease
27-Jul-21
{{comment.datetimestampdisplay}}}
{{comment.comments}}